Dermatology Times

Dermatology’s 2017 Game Changers

We asked dermatologists what they predict will be the specialty’s game-changers in 2017. This is what they had to say:

Harper Price, MD | Jessie Cheung, MD | NYC NY

Harper N. Price, M.D.Harper N. Price, M.D., pediatric dermatology division chief, Phoenix Children’s Hospital, tells Dermatology Times that she’s looking forward to new and exciting treatments for pediatric atopic dermatitis (AD).

“A new topical formulation (a phosphodiesterase-4 inhibitor) for pediatric AD is slated to be on the market in early 2017,” Dr. Price says. “Clinical trials for biologic therapies for severe pediatric AD will also be underway. There is currently little evidence-based literature supporting treatments for severe AD in childhood and adolescence. These new trials will be a welcomed addition, hopefully bringing better treatment options to the table.” (No conflicts)

It is an exciting time in dermatology, as there continues to be a shift in the understanding of the pathophysiology of many disease states, bringing new therapies for difficult to treat conditions, according to medical, cosmetic and surgical dermatologist Jennifer Salsberg, M.D., of Women’s College Hospital, Toronto, Ontario.

“I am looking forward to the new treatments on the horizon for atopic dermatitis, both topical and systemic, especially new biologic agents targeting specific inflammatory mediators implicated in atopic dermatitis,” Dr. Salsberg says. “We will soon have exciting new options to help patients with this chronic and sometimes debilitating condition.”

Jessie Cheung, M.D., director of the Dermatology & Laser Center in Willowbrook, Ill., says there’s a movement towards dispensing prescription medications in the office, and bypassing pharmacies and insurance companies.

“It’s frustrating to both me and my patients when my desired treatment plan is denied,” Dr. Cheung says. “Now, my patients can walk out of my office with the correct medications. I do hope that the healthcare dilemma gets sorted out in 2017.”

On another note, Dr. Cheung says her favorite new procedure involves the use of absorbable sutures to suspend and re-orient the skin. Dr. Cheung uses Silhouette InstaLift (Silhouette Lift Inc.) and NovaThreads (Aesthetic Experts Laboratory).

“They are a great complement to filler injections, since they can lift a jowl, or nasolabial fold, without adding heaviness to the skin. These sutures really can be used anywhere in the body. In addition to the face, I’ve had great success with lifting buttocks, and knees.” (Dr. Jessie Cheung, Dermatology Times).

Debra Jaliman | Jessie Cheung, MD | NYC NY

Debra Jaliman“I think PRP injections made of platelet rich plasma will be big for 2017,” says Debra Jaliman, assistant clinical professor of dermatology, at the Icahn School of Medicine at Mount Sinai, New York, N.Y. “I use it in my practice for acne scars, anti-aging and hair loss. The treatments are given four to six weeks apart and are well tolerated. The results are impressive, and you don’t have to worry about allergic reactions.”

Click here to read more. 

Request Appointment

Get Directions
New York, NY

Request an Appointment

  • * All indicated fields must be completed.
    Please include non-medical questions and correspondence only.
  • This field is for validation purposes and should be left unchanged.

Social Media

Our NY Office

Main Office
635 Madison Avenue, 4th Floor
New York, NY 10022
Get directions »